RAJIV GANDHI UNIVERSITY OF HEALTH SCIENCES
RAJIV GANDHI UNIVERSITY OF HEALTH SCIENCES
BANGALORE, KARNATAKA
ANNEXURE – 11
SYNOPSIS FOR REGISTRATION OF SUBJECTS FOR DISSERTATION
1. NAME OF THE CANDIDATE DR BHAGYALAKSHMI K
AND ADDRESS ROOM NO 309,
(in block letters) VISHRANTHI DHAMA, FORT,
BANGALORE 560002
2. NAME OF THE INSTITUTION BANGALORE MEDICAL COLLEGE
AND RESEARCH INSTITUTE,
BANGALORE.
3. COURSE OF STUDY AND M.S. OPHTHALMOLOGY
SUBJECT
4. DATE OF ADMISSION TO THE 28TH MAY 2010
COURSE
5. TITLE OF THE TOPIC STUDY OF FEASIBILITY OF
TOPICAL TACROLIMUS 0.03%
OINTMENT IN INTRACTABLE
ALLERGIC CONJUNCTIVITIS AT
MINTO AND BOWRING & LADY
CURZON HOSPITAL, BANGALORE
6. BRIEF RESUME OF THE INTENDED WORK
6.1 NEED FOR THE STUDY
Allergic conjunctivitis is one of the most common benign external ocular conditions encountered in general ophthalmic practice.1 Allergic eye disease is estimated to affect 20% of population world wide.2 Infrequently a severe chronic form can be debilitating and vision threatened when corneal surface is disrupted.1,3 Histologically eosinophils, mast cells, neutrophils and activated T cells are seen in conjunctival cytology.4 Treatment is usually based on eye drops containing anti histamines, mast cell stabilizers or dual action agents which is often insufficient necessitating the addition of
steroids.1,3-5 However the risk of glaucoma, cataract and super infection limits the use of steroids to short course.
Tacrolimus also known as FK–506 is a macrolide derivative with immunomodulatory and anti-inflammatory activity. Produced by the fungus Streptomyces tsukubaenis, it suppresses T cell activation and IL-2 production by binding to an immunophilin and inhibiting the enzymatic activity of calcineurin.6 Hence this study is undertaken to study the potential feasibility of commercially available 0.03% tacrolimus ointment in conjunctival sac for the treatment of patients with intractable allergic conjunctivitis.
2. REVIEW OF LITERATURE
Liat Atlas Fox, et al studied the feasibility of tacrolimus 0.03% dermatologic ointment in the treatment of intractable allergic conjunctivitis. They concluded that tacrolimus 0.03% ointment is effective well tolerated and safe.1
Trocme, et al studied the immunologic spectrum of five basic types of ocular allergy and the prevalence. They concluded that ocular allergic eye disease is a common problem affecting about 20% of population world wide and the differences and similarities observed might help to better treat the patients.2
.
Pakit Vichyanond, et al studied result of novel therapy with 0.1% topical ophthalmic FK 506 ointment, results indicated a highly favourable response in vernal keratoconjunctivitis & concluded that lower concentration of FK -506 can be tried in future studies. Absorption of FK-506 from conjunctiva was negligible as observed from skin of patients with atopic dermatitis.3
Hannele M, et al studied effect of tacrolimus 0.03% ointment on conjunctival cytology in patients with severe atopic blepharo conjunctivitis. They concluded that tacrolimus ointment is safe and effective treatment for atopic blepharo conjunctivitis. Regular treatment of eyelids once daily may lead to clinical and cytological improvement of conjunctivitis.4
George D Kymionis, et al studied effect of Tacrolimus 0.03% ointment for treatment of Giant papillary conjunctivitis. They concluded that tacrolimus is effective treatment for severe Giant papillary conjunctivitis.5
Poorna Abeysiri, et al studied the use of topical tacrolimus 0.1% skin ointment for anterior segment inflammations. They concluded that it has a role for treatment for steroid resistant cases of vernal keratoconjunctivitis and atopic keratoconjunctivitis.6
3. AIMS AND OBJECTIVES OF STUDY
To study the feasibility of application of commercially available tacrolimus 0.03% dermatologic ointment into the conjunctival sac for the treatment of patients with intractable allergic conjunctivitis.1
7. MATERIALS AND METHODS
7.1 SOURCE OF DATA
Patients attending Minto Ophthalmic Hospital and Bowring and Lady Curzon Hospital during the period of October 2010 to October 2011
7.2 METHOD OF COLLECTION OF DATA
It is a prospective interventional hospital based study of 30 intractable allergic conjunctivitis patients. Existing ocular treatment have to be discontinued at enrollment. Tacrolimus 0.03% ointment shall be applied into conjunctival sac of affected eyes once daily for 10 weeks followed by a 2 weeks washout period. Conjunctivitis severity shall be recorded with a composite subjective & objective score at each visit. Patients will be followed up twice a week in the first week, weekly for next three visits and once in two weeks for another four visits.
INCLUSION CRITERIA :
• Subjects both males and females >5years of age suffering from intractable allergic conjunctivitis
EXCLUSION CRITERIA :
• Pregnancy
• Breast feeding
• History of herpetic eye disease
• Transplant patients
• Concomitant administration of drugs inhibiting cytochrome CYP3A4
• Hypersensitivity to macrolides
• Adnexal and ocular infection
STATISTICAL METHOD : paired t test
3. DOES THE STUDY REQUIRE ANY INVESTIGATIONS OR INTERVENTIONS TO BE CONDUCTED ON PATIENTS OR OTHER HUMANS OR ANIMALS? ( IF SO DESCRIBE BRIEFLY)
Yes the study involves the following investigations and interventions on
patients
- visual acuity testing for distance and near
- intra ocular tension
- slit lamp biomicroscopic examination
- direct ophthalmoscopy
- pre and post treatment slit lamp assisted external ocular photography
4. HAS THE ETHICAL CLEARANCE BEEN OBTAINED FROM YOUR INSTITUTION IN CASE OF 7.3? Yes
8. LIST OF REFERENCES
JOURNAL REFERENCES
1. L. A. Fox , Y Barkana, V Iskhakov and Svetlana R .Topical tacrolimus 0.03%
ointment for intractable allergic conjunctivitis. Current Eye Research .
2008;33:545-549.
2. Trocme SD, Sra K K. Spectrum of ocular allergy. Curr Opin Allergy Clin
Immunol. 2002;2:423-427
3. Pakit V, Chiraphan T, Puttachart D, Orathai J,Nualanong V & Panida K.
Vernal keratoconjunctivitis; Result of a novel therapy with 0.1% topical
ophthalmic FK 506 ointment. J Allergy Clin Immunol. 2004;113:355-358.
4. Hannele M.V., Sakari R, Marjatta K and Osmo Kori. Effect of tacrolimus
ointment on conjunctival cytology in patients with atopic blepharoconjunctivitis
Acta Ophthalmol Scand. 2006;84:693 – 695.
5. George D.k., David G, Takesh ide and Sonia. Tacrolimus ointment 0.03% for
treatment of Giant papillary conjunctivitis. Cornea. 2008;27:228-229.
6. Poorna A, Nichol as RJ and Anthony C B Molteno . Use of 0.1% topical
tacrolimus ointment for anterior segment conditions a case series.
Ophthalmology and eye diseases 2010;2:5-8.
9. SIGNATURE OF CANDIDATE
10. REMARKS OF THE GUIDE
Allergic conjunctivitis is a common clinical occurrence . Despite its benign natural course sight threatening complications occur in some forms of allergic conjunctivitis. This study under my guidance will help to know the advantages of topical tacrolimus 0.03% ointment in intractable allergic conjunctivitis.
11 NAME AND DESIGNATION OF THE
11.1 GUIDE DR SHIVKUMAR
M.B.B.S., M.S., D O M S,
PROFESSOR OF OPHTHALMOLOGY,
BOWRING AND LADY CURZON
HOSPITAL,
BANGALORE MEDICAL COLLEGE
AND RESEARCH INSTITUTE,
BANGALORE.
11.2 SIGNATURE
11.3 CO GUIDES IF ANY NONE
11.4 SIGNATURE
11.5 HEAD OF THE DEPARTMENT DR RAVIPRAKASH,
M.B.B.S., M.S.(OPH)
MINTO OPHTHALMIC HOSPITAL
AND REGIONAL INSTITUTE
BMC & RI
BANGALORE.
11.6 SIGNATURE
11.7 DIRECTOR DR SRI PRAKASH
MOH&RI M.B.B.S., M.S.(OPH)
MINTO OPHTHALMIC HOSPITAL
AND REGIONAL INSTITUTE
BMC AND RI
BANGALORE 560002
11.8 SIGNATURE
11.9 REMARKS OF THE DEAN AND DIRECTOR
BMC&RI
11.10 SIGNATURE
................
................
In order to avoid copyright disputes, this page is only a partial summary.
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.
Related searches
- archives of biological sciences journal
- definition of social sciences pdf
- blackrock health sciences fact sheet
- list of social sciences degrees
- blackrock health sciences trust
- blackrock health sciences stock
- archives of biological sciences impact
- institute of mathematical sciences chennai
- university of natural health scam
- university of texas health system
- university of tampa health center
- university of medical sciences ondo